Amiigo is now Wavelet Health!

At the inception of Amiigo, our mission was to utilize contextually rich sensor data from multiple wearable devices to better understand the human body and provide relevant user feedback.



Like many startups, we encountered some road bumps and it took us some time to find our footing. We apologize for the silence, but we’re back to share our journey and discoveries.. We first saw the potential of Amiigo’s technologies in a clinical environment while collecting data in our first research study with the University of Utah cardiovascular center. We quickly learned that there was the opportunity to revolutionize how patient data can be collected and interpreted to improve the quality of care. As a result, we chose to redirect our resources to building the world’s first health platform leveraging wearable, mobile and cloud technologies to facilitate groundbreaking innovations in health research.

We’re excited to announce today that Amiigo has evolved into Wavelet Health (www.wavelethealth.com), a company focused on facilitating innovations in clinical research. Wavelet has had a variety of achievements over the last 12 months. Most recently Wavelet Health’s wearables were recognized as the first to be used in a drug trial. See this press release from one of our partners describing an exemplary use of the Wavelet platform in Hypertrophic Cardiomyopathy patients.

Wavelet now works with clinics, academia, pharmaceutical companies, insurance providers and other research-focused organizations who conduct and sponsor health research initiatives. To learn more about some of our previous or current work and existing partners, or to inquire about a partnership with Wavelet, please email us at info@wavelethealth.com.

Similar to Amiigo, Wavelet’s platform consists of multi-device framework with many different sensors (accelerometers, gyroscopes, temperature, GPS and PPG), mobile apps (iPhone, iPad and Android) and proprietary signal processing and machine learning algorithms running in our cloud. Wavelet utilizes these tools collectively to accelerate discoveries in health research.

Wavelet just released a new wristband and shoe pod and is continuing to build upon the multi-device approach by incorporating additional sensors and devices to broaden the scope of addressable therapeutic areas. Today, our products are being used in research spanning everything from Oncology, Sleep Disorders, Cardiology and Neurology. In the future, Wavelet plans to integrate with other 3rd party devices to further enrich the context of the data collected from patients. To learn more about how to integrate with Wavelet, send us an email at partnerships@wavelethealth.com.

The Amiigo apps will remain available, but no further development will be done. Biostrap, our consumer facing partner, is utilizing a portion of Wavelet’s core technology with a focus on revolutionizing health and fitness tracking. See www.biostrap.com for more information on consumer-centric experiences powered by Wavelet. To read more on the relationship between Biostrap and wavelet, please see their recent blog post here.

We appreciate your support over the years! If you have any other questions, please drop us a line at at contact@wavelethealth.com. Future updates can be found on our Wavelet blog.

Be on the lookout for more exciting things to come..

-the Wavelet team